Camarda Financial Advisors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-11,826
| Closed | -$1.69M | – | 89 |
|
|
2024
Q2 | $1.69M | Buy |
+11,826
| New | +$1.69M | 0.66% | 52 |
|
|
2024
Q1 | – | Sell |
-1,976
| Closed | -$204K | – | 82 |
|
|
2023
Q4 | $204K | Buy |
+1,976
| New | +$204K | 0.09% | 78 |
|
|
2022
Q4 | – | Sell |
-6,336
| Closed | -$316K | – | 86 |
|
|
2022
Q3 | $316K | Buy |
+6,336
| New | +$316K | 0.37% | 52 |
|
|
2019
Q3 | – | Sell |
-1,190
| Closed | -$30K | – | 333 |
|
|
2019
Q2 | $30K | Buy |
1,190
+132
| +12% | +$3.33K | 0.06% | 105 |
|
|
2019
Q1 | $28K | Buy |
+1,058
| New | +$28K | 0.05% | 110 |
|
|
2016
Q4 | – | Sell |
-550
| Closed | -$11K | – | 276 |
|
|
2016
Q3 | $11K | Hold |
550
| – | – | 0.01% | 172 |
|
|
2016
Q2 | $15K | Buy |
+550
| New | +$15K | 0.01% | 194 |
|
|
2013
Q3 | – | Sell |
-290
| Closed | -$4K | – | 185 |
|
|
2013
Q2 | $4K | Buy |
+290
| New | +$4K | ﹤0.01% | 218 |
|